Bristol-Myers to Buy Turning Point Therapeutics for $4.1 Billion - WSJ
Episode Guide for Microsoft Women in Business & Technology podcast
This billionaire has quietly driven Boston's biotech industry for decades - The Boston Globe
Product Launch Film Production for New Balance | CGI
Kelo Eminent Domain - Institute for Justice
Pfizer dominates the COVID drug market. This Watertown biotech wants to change that. - The Boston Globe
Politics, Science and the Remarkable Race for a Coronavirus Vaccine - The New York Times
Strong Bacterial Cellulose-Based Films with Natural Laminar Alignment for Highly Sensitive Humidity Sensors | ACS Applied Materials & Interfaces
Biotech Company Says Citadel Securities, Other Big Traders Manipulated Its Stock Price - WSJ
Coronavirus: Covid News: U.S. to Tighten Testing for Travelers Amid Omicron Worries - The New York Times
Identification and Characterization of an Allosteric Inhibitory Site on Dihydropteroate Synthase | ACS Chemical Biology
Merck Explores Purchase of Biotech Seagen - WSJ
Fashion industry efforts to address global PPE shortages – Update - Just Style
The WeWork Documentary Explores a Decade of Delusion | The New Yorker
Polymers | Free Full-Text | Multipurpose Prevention Technologies: Oral, Parenteral, and Vaginal Dosage Forms for Prevention of HIV/STIs and Unplanned Pregnancy
Fierce Biotech's 2022 Fierce 15
Humanities | Free Full-Text | The 1930s Horror Adventure Film on Location in Jamaica: 'Jungle Gods', 'Voodoo Drums' and 'Mumbo Jumbo' in the 'Secret Places of Paradise Island'
Elon University / Imagining the Internet / Anonymous Responses: New Normal for Digital Life 2025
AbbVie | Pharmaceutical Research & Development
McKesson | Medical Supplies, Pharmaceuticals & Healthcare Solutions
November / December 2022 - Cornellians | Cornell University
Life sciences is poised to be Boston's dominant industry. Has the area become the Silicon Valley of biotech? - The Boston Globe
Marcum LLP and Friedman LLP Announce Plans to Merge | Marcum LLP | Accountants and Advisors
Icon to Buy Clinical-Trial Rival PRA in $12 Billion Deal - WSJ
